EUCTR2010-019004-24-IT进行中（未招募）不适用
ANDROGEN DEPRIVATION THERAPY WITHDRAWAL VERSUS MAINTENANCE AND INTERMITTENT DOCETAXEL THERAPY VERSUS CONTINUOUS ADMINISTRATION IN PATIENTS WITH PROSTATE CANCER RESISTANT TO CHEMICAL CASTRATION - PON-PC-02
AZIENDA OSPEDALIERA S. LUIGI GONZAGA0 个研究点开始时间: 2010年5月18日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •1) prostatic adenoca with histological confirmation and clinical or radiological evidence of metastatic desease 2) metastatic desease hormone refractory 3) desease progression defined as PSA increase >50% compared with nadir
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1)serum PSA increase without radiological evidence of metastatic desease 2) previous chemoteraphy for prostatic ca 3) peripheral neuropathy >G1
研究者
相似试验
进行中（未招募）
4 期
The effect of intermittent versus continuous androgen deprivation therapy in Chinese patients with advanced prostate cancer: A prospective controlled Trial from ChinaCancer - Prostateprostate cancerACTRN12613000107729Changhai Hospital, Second Military Medical University100
进行中（未招募）
1 期
Comparison of targeted radiotherapy with and without short-term hormonal treatment (6 months)CTIS2024-511252-41-00niversitair Medisch Centrum Groningen280
进行中（未招募）
不适用
Trial investigating hormone injections, external beam radiotherapy and intravenous radionuclide injection in patients with advanced prostate cancer.Metastatic castration sensitive prostate cancerEUCTR2014-000273-39-GBBelfast Health and Social Care Trust
尚未招募
3 期
Effect of systematic lifestyle advice & use of cholesterol reducing drugs on cardiovascular disease outcomes among men with newly diagnosed prostate cancer on androgen deprivation therapy.CTRI/2023/07/054807Dr Jehonathan Pinthus Dr Leong Darryl
进行中（未招募）
1 期
The effect of androgen deprivation therapy on the expression of prostate specific membrane antigeMedDRA version: 20.0 Level: PT Classification code 10036909 Term: Prostate cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0 Level: PT Classification code 10071119 Term: Hormone-dependent prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Metastatic prostate cancerEUCTR2018-004853-26-FITurku University Hospital35